Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483 Response
  6. /
  7. Abbott Medical
483 RESPONSE
•Abbott Medical•October 17, 2012

FDA 483_RESPONSE - Abbott Medical - October 17, 2012

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Abbott Medical
Record Details

This 483 RESPONSE record concerns Abbott Medical, with an inspection on October 17, 2012, issued by the Los Angeles District Office, covering drugs.

Company
Abbott Medical
Inspection Date
October 17, 2012
Product Type
Drugs
Office
Los Angeles District Office
People
  • Alonza E. Cruse (Director)
  • Philip Tsung
Open in Dashboard

ID · 581f7586-f63a-4294-825a-35efa937ef9d

Violation Codes1
21 CFR 210

Full citation text and observation details available on the Dashboard.

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.